Curative Biotechnology Inc Stock Agreements
10 Contracts & Agreements
- Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021 (Filed With SEC on November 7, 2022)
- Specimen of Series C Preferred Stock (Filed With SEC on November 7, 2022)
- Specimen of Series B Preferred Stock (Filed With SEC on November 7, 2022)
- Specimen Series A Preferred Stock (Filed With SEC on November 7, 2022)
- Specimen of Common Stock Certificate (Filed With SEC on November 7, 2022)
- Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021 (Filed With SEC on September 30, 2022)
- Specimen of Series C Preferred Stock (Filed With SEC on April 15, 2022)
- Specimen of Series B Preferred Stock (Filed With SEC on April 15, 2022)
- Specimen Series A Preferred Stock (Filed With SEC on April 15, 2022)
- Specimen of Common Stock Certificate (Filed With SEC on April 15, 2022)